Acta rheumatologica - Institut za reumatologiju

19) Guldman H-A, Szosteki C, Vosberg H-P, Lakomek HJ, Penner E, Bautz FA. Scl-70
autoantibodies from scleroderma patients recognize a 95 kDa protein identiified as topoisomerase
I. Chromosoma 1986;94:132-138.
20) Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM. Correlates between autoantibodies to
nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis
Rheum. 1988;31:525-32.
21) von Muhlen CA, TAn EM, Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin
Arthritis Rheum 1995;24:323-358.
22) 22)Humbel RL. Detection of antinuclear antibodies by immunofluorescence. Van Venrooij WJ
Maini RN eds. Manual of biological markers of disease 1993. Kluwer Academic Publishers
Dordrecht, The Netherlands. A2:1-16
23) 23) Reveille JD, Solomon DH. American College of Rheumatology, ad hoc Committee on
immunologic testing Guidelines: Evidence based guidelines for the use of immunological tests:
anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003;49:399-412.
24) 24) Lane SK,Gravel JW. Clinical utility of common serum rheumatologic tests. Am Fam
Physician 2002;65:1073-80.
25) 25)Weiner ES, Earnshaw WC, Senecal J-L, Bordwell B Johnson P, Rothfield NF. Clinical
association od anticentromere antibodies and antibodies to topoisomerase I. A study of 355
patients. Arthritis Rheum 1988;31(3):378-385.
26) 26) Petrović M, Damjanov N, Mirčetić V,Srejić Lj. Nalaz anti-Scl-70 i anti-DNK antitela kod
bolesnika sa sistemskom sklerozom. Abstrakt. Acta rheum Belgrad 1998; 28 (supl.1): S-52, 109 .
27) 27) Shoenfeld Y, Grunebaum E, Laufer M, Zurgil N, Bakimer R, Lunderschmidt A,Valentini G,
Tirri G, Blank M. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
Isr J Med Sci. 1996 ;32(7):537-42.
28) 28) Cepeda EJ, Reveille JD. Autoantibodies in systemic sclerosis and fibrosing
syndromes:cliniclal indications and relevance. Curr Opin Rheumatol 2004;16:723-732.
29) 29)Dick T, Mierau R, Bartz-Bazzanella P, Alavi M, Stoyanova-Scholz M, KindlerJ, and Genth
E Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic
sclerosis Ann. Rheum. Dis 2002; 61(2): 121 - 127.
30) 30) Ho K T, Reveille JD. The clinical relevance of autoantibodies in scleroderma Arthritis Res
Ther 2003;5:80-93.
31) 31)Tan EM, Rodnan GP,Garcia i, Moroi Y,Fritzler i Elkon 2003 MJ. Peebles C. Diversity of
antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its
relationship to CREST syndrome. Arthritis rheum 1989;23:617-625.
32) 32) Kipnis RJ, Craft J,Hardin JA. The analysis of antinuclear and antinucleolar autoantibodies in
scleroderma by radioimmunopecipitation assay. Arthritis Rheum 1990;33(9):1431-1437.